NIH-funded research NIH-funded research

Peptides to block the gum bacterium P. gingivalis

Official title: Development and characterization of anti-P. gingivalis peptides

Funded at Meharry Medical College · NIH-11379463 · Data updated 2026-11-12

Researchers are creating small protein pieces (peptides) that aim to stop P. gingivalis, a bacterium linked to periodontitis, to help people with gum disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMeharry Medical College
NIH-funded
Lab location1 site (Nashville, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2026
Award (this year)$145,500
NIH project number5R16GM149359-04
Project IDNIH-11379463 on NIH RePORTER

Who could benefit from this research

Could help

Adults with chronic periodontitis, especially those known or suspected to have P. gingivalis involvement, would be the main beneficiaries and likely candidates for later-stage testing.

Less likely to help

People without P. gingivalis-related gum disease, those with primarily non-infectious dental problems, or those needing urgent dental surgery are unlikely to benefit directly from this preclinical work.

What this research studies

This project develops small peptides based on a protein piece (SAPP) from a mouth bacterium that naturally suppresses P. gingivalis. The team will design and test these peptides in the lab to see if they stick to P. gingivalis surface proteins and lower expression of genes that make the bacterium harmful. They will identify which bacterial receptors the peptides target and measure whether treated bacteria are less able to damage gum tissues in laboratory models. If laboratory results are promising, the work could lead to testing samples or treatments that might be offered to people with periodontitis in later stages.

Why it matters

Potential benefit: If successful, this could lead to new treatments that reduce P. gingivalis virulence and help prevent or limit gum tissue damage from periodontitis.

How similar studies have gone: Anti-virulence approaches are relatively new but prior laboratory work showing that Streptococcus cristatus molecules can suppress P. gingivalis supports this as a promising preclinical direction.

Where this research is happening

  • Meharry Medical College
    Nashville, United States
    Active

Researchers

  • Principal investigator: Wang, Qingguo — Meharry Medical College
  • Study coordinator: Wang, Qingguo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.